News

Ideas That Generate Results

The recent spurt in emerging markets has directly impacted the pharmaceutical industry. Rising affordability, enhanced life expectancy and improved standard of living are all providing impetus to the demand for pharmaceuticals. However, major regulatory changes in the United States and Europe along with rising labor costs in China are set to change the API landscape. As patterns in developed regions continue to remain flat and opportunities for growth shift from traditional markets, the API industry is expected to witness the rise of second wave emerging markets in countries such as Brazil, Mexico, South Korea and Taiwan.
 
Latin America’s regulatory oversight, investment in domestic specialty manufacturing capabilities, formation of a growing number of partnerships and infrastructure help this region to be an important area for sourcing low-cost, active pharmaceutical ingredients. On the other hand, Taiwanese API producers have gained recognition for high quality and international good manufacturing practices (GMP) compliance. For countries in Eastern Europe such as Ukraine, things started changing when GMP standards became obligatory for Ukrainian pharmaceutical producers in 2010. Ukraine's regulatory improvements have also encouraged foreign pharmaceutical companies to increase their presence in the country, and an increasing number of collaborations are emerging between local Ukrainian manufacturers and foreign companies. Such developments are expected to provide a major impetus to the API space in Ukraine and other eastern European countries.
 
According to our report, “Global API Market Outlook 2018”, in the wake of the above developments, the Global API industry is expected to grow at a CAGR of 9.4% from 2013-2018. The market has been divided into four major geographies which comprise Americas, Asia, Europe and the rest of the world. For every region, a current and future outlook of the API industry has been provided. We have also deduced a list of top countries which will be responsible for the majority of API related activities. These countries include the likes of US, Italy, Japan, China, India and South Korea. For every such country a current and future outlook of the API industry has been presented along with the regulatory scenario pertaining to API manufacturing and trade. A future opportunity assessment of every region has also been done to help highlight the areas that have promising possibilities.
 
As the days of the blockbuster drugs start waning, more flexible manufacturing focused on personalized medicines can be seen as the future of the pharmaceutical business. The report elaborates on the rise of more such trends and challenges and their possible impacts on the industry.
 
Apart from the major markets and trends, we have covered the key players of the Merchant API Market. For every player, a brief business overview, geographic revenue break-up and segment-wise revenue break-up, along with key financials have been provided. A strength and weakness analysis of every player has also been presented to assist industry-based investors in developing an understanding of these players’ strategies. Overall, the research contains exhaustive information that will help clients in formulating their market strategies and assessing opportunity areas in the global API market.
 
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM709.htm
 
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm